ABT-414 Clinical Trials

TrialTitleStudy Record DetailPhaseSponsor/Colaborator
ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent GlioblastomaNCT02343406 IAbbVie/EORTC
A Study of ABT-414 in Subjects With Solid TumorsNCT01741727 IAbbVie (prior sponsor, Abbott)
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma MultiformeNCT01800695 IAbbVie
Study Evaluating ABT-414 in Japanese Subjects With Malignant GliomaNCT02590263 IAbbVie/EORTC
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification (Intellance1)NCT02573324 IIAbbVie/EORTC